NCT06543628View on ClinicalTrials.gov

Evaluation of Tadalafil Combined With LIPUS for Treating Erectile Dysfunction

NACompletedINTERVENTIONAL
Enrollment

114

Participants

Timeline

Start Date

August 11, 2024

Primary Completion Date

March 1, 2025

Study Completion Date

March 3, 2025

Conditions
Erectile Dysfunction
Interventions
DRUG

Tadalafil 5mg

Participants will take tadalafil once daily at a dose of 5 mg for 6 months.

DEVICE

LIPUS (Low Intensity Pulsed Ultrasound)

Participants will receive LIPUS treatment applied twice a week for 4 weeks, with the cycle repeated after a 4-week interval without treatment.

Trial Locations (1)

310009

The 2nd Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou

All Listed Sponsors
lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER

NCT06543628 - Evaluation of Tadalafil Combined With LIPUS for Treating Erectile Dysfunction | Biotech Hunter | Biotech Hunter